New developments in cystic fibrosis

Pediatric Annals

Volumn 27, Issue 8, 1998, Pages 515-520

  Hudson, Valera L ^a   Guill, Margaret F ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; RETINOL; VITAMIN D; VITAMIN K GROUP;

CLINICAL FEATURE; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DISEASE ACTIVITY; GENE THERAPY; HUMAN; LUNG DISEASE; PANCREAS INSUFFICIENCY; REVIEW; VITAMIN INTAKE;

EID: 0031874445     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19980801-10     Document Type: Review

References (22)

1. Davis PB, Drumm M, Konstan MW. State of the art: Cystic fibrosis. Am J Respir Crit Care Med. 1996;154:1229-1256.
2. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
3. FitzSimmons SC. Cystic fibrosis foundation patient registry annual report. Cystic Fibrosis Foundation, Patient Registry 1996 Annual Data Report, Bethesda, Maryland, August 1997.
4. Collins FS. Cystic fibrosis: Molecular biology and therapeutic implications. Science. 1992;256:774-779.
5. Anderson DH. Cystic fibrosis of the pancreas and its relationship to celiac disease: A clinical and pathologic study. Am J Dis Child. 1938;72:344-399.
6. DiSant'Agnese PA, Darling RC, Perera GA, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas: Clinical significance and relationship of the disease. Pediatrics. 1953;12:549-563.
7. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959;23:545-549.
8. Hamosh A, FitzSimmons SC, Macek M, et al. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998;132:255-259.
9. Farrell PM, Kosorok MR, Laxove A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med. 1997;337:963-969.
10. Thomson MA, Wilmott RW, Wainwright C, et al. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J Pediatr. 1996;129:367-373.
11. LeGrys VA. Sweat testing for the diagnosis of cystic fibrosis: practical considerations. J Pediatr. 1996;129:892-897.
12. Smyth RL, vanVelsen D, Smith AR, et al. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994;343:85-86.
13. FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336:1283-1289.
14. Borowitz DS, Grand RJ, Dune PR, et al. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. J Pediatr. 1995;127:681-684.
15. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996;335:179-188.
16. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med. 1994;331:637-642.
17. Eigen H, Rosenstein BJ, FitzSimmons S, et al. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J Pediatr. 1995;126:515-523.
18. Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med. 1995;332:848-854.
19. Ramsey BW, Burns J, Smith A. Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis: The results of two phase III placebo controlled clinical trial. Pediatr Pulmonol. 1997;suppl. 14:137-138.
20. Church DA, Kanga JF, Kuhn RJ, et al. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazadime/tobramycin in the treatment of acute pulmonary exacerbations. Pediatr Infect Dis J. 1997;16:97-105.
21. Schaad UB, Wedgwood J, Ruedeberg A, et al. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr Infect Dis J 1997;16:106-111.
22. Rosenfield MA, Yoshimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992;68:143-155.